MITSSITShandong Intervention TrialCRCcolorectal cancer
… with successful eradication (HR=0.38, 95% CI 0.15 to 0.94). In MITS, no overall benefit was observed 13.8 years after treatment (HR…
6articles mentioning institutions
18institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: MITS ×
MITS
This institution is selected. Its supporting articles are shown below.
Articles mentioning MITS
6 articles · page 1 of 1MITSUK Biobank Pharma Proteomics ProjectUKBUKB-PPPgastric cancer
…within the Mass Intervention Trial in Linqu, Shandong Province (MITS, n=300) ( IDDF2026-ABS-0454 Figure 1. Study workflow). Plasma a…
MITSSITShandong Intervention TrialNCT00155389gastric cancerChiCTR-TRC-10000979GCH.pylori
…pylori treatment, with their CATEs aggregated into the PTBS. In MITS, targeting the high-treatment-benefit subgroup reduced GC risk …
MITSUK BiobankUKBUGCEDUpper Gastrointestinal Cancer Early Detection ProgramSITgastric cancerGC
…raging the Mass Intervention Trial in Linqu, Shandong Province (MITS; n=2804), with replication in the Upper Gastrointestinal Cancer…
MITSgastric cancerHP0305GCGCAbstractanti-H. pylori treatmentCagAOmp
…c susceptibility.Methods Based on post-unblinding data from the MITS (2011-2022), we designed a nested case-cohort study. Genetic an…
UK BiobankMITSUKBBUGCEDSITUpper Gastrointestinal Cancer Early Detection programgastric cancer
…bolomic data from 436,480 participants across five cohorts: the UK Biobank (UKBB) Discovery (n=145,857) and Test (n=284,694) cohorts, and …